Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
We postulate that multiple apoptototic events are indusce through testosterone depletion and
repletion with taxotere given in conjunction with androgen withdrawal.